MABSELECT SURE LX 200 ML
La imagen es solo una referencia, puede diferir e incluir accesorios no disponibles en el producto.
¡Confirmar el precio actual! más IVA (21%) más costes de envío
MABSELECT SURE LX 200 ML
MABSELECT SURE LX 200 MLMabSelect SuRe LX is an alkali-stabilized, protein A-derived affinity medium with a binding capacity for monoclonal antibodies (MAbs) exceeding that of MabSelect SuRe at longer residence times, This special combination of high binding capacity plus alkaline stability gives manufacturers of MAbs many opportunities to improve process economics and product quality, MabSelect SuRe LX, 200 ml MabSelect SuRe LX is a protein A affinity medium with very high dynamic binding capacity at extended residence times and is developed for high titer antibody processes. Alkali tolerance, high capacity and low ligand leakage in combination with the rigid base matric makes MabSelect SuRe LX highly suitable for purification of monoclonal anitbodies for clinical applications. Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH. Reduces the risk of product contamination and carryover Improves performance and reduces overall costs High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used Generic elution profile for different monoclonal antibodies enables platform approach to purification High-flow agarose matrix allows the processing of large feed volumes MabSelect SuRe LX is a member of the MabSelect family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect SuRe LX shares features and benefits of MabSelect and MabSelect SuRe such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. It also features the same alkali-tolerant rProtein A ligand as MabSelect SuRe. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect SuRe improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl. Process economy is also improved by the increased dynamic binding capacity of MabSelect SuRe LX. Just as for MabSelect SuRe, the novel ligand construct of MabSelect SuRe LX has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect SuRe LX ligand during elution is low. MabSelect SuRe has been demonstrated to give generic elution conditions for different monoclonal antibodies which can be applied also to MabSelect SURe LX since it utilizes the same ligand. This is an advantage when designing generic purification platform processes. The feature is also correlated to the construction of the MabSelect SuRe ligand MabSelect SuRe LX is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect SuRe meets industrial demands with security of supply and comprehensive technical and regulatory support.
Package Content: 200 MLT
Reference Num.: GE17547402
| (-) Datos técnicos: | |
|---|---|
| Esterilidad: | No |
| (-) Datos relacionados con la seguridad: | |
|---|---|
| Palabra de advertencia: | Flammable Liquids - FL |
-
- Fabricante: Cytiva
- Artículo-núm.: 17-5474-02
- Categoría: Antígenos y anticuerpos
Show all Antígenos y anticuerpos from Cytiva - Paquete: 200 Mililitro
- Validez: 31.12.2025
- Última actualización: 09.01.2025


